Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson’s Disease
Ju-Hee Kang
JMD. 2016;9(2):89-96.   Published online 2016 May 25     DOI: https://doi.org/10.14802/jmd.16017
Citations to this article as recorded by Crossref logo
Why would Parkinson’s disease lead to sudden changes in creativity, motivation, or style with visual art?: A review of case evidence and new neurobiological, contextual, and genetic hypotheses
Jon O. Lauring, Tomohiro Ishizu, Hana H. Kutlikova, Felix Dörflinger, Steven Haugbøl, Helmut Leder, Ron Kupers, Matthew Pelowski
Neuroscience & Biobehavioral Reviews.2019; 100: 129.     CrossRef
Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
Tracy R. Melzer, Megan R. Stark, Ross J. Keenan, Daniel J. Myall, Michael R. MacAskill, Toni L. Pitcher, Leslie Livingston, Sophie Grenfell, Kyla-Louise Horne, Bob N. Young, Maddie J. Pascoe, Mustafa M. Almuqbel, Jian Wang, Steven H. Marsh, David H. Mille
Frontiers in Neurology.2019;[Epub]     CrossRef
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
Kurt A. Jellinger
Journal of Neural Transmission.2018; 125(4): 615.     CrossRef
Identification of a prospective early motor progression cluster of Parkinson's disease: Data from the PPMI study
George D. Vavougios, Triantafyllos Doskas, Constantinos Kormas, Karen A. Krogfelt, Sotirios G. Zarogiannis, Leonidas Stefanis
Journal of the Neurological Sciences.2018; 387: 103.     CrossRef
Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease
Nooshin Abbasi, Bahram Mohajer, Sima Abbasi, Payam Hasanabadi, Amirhussein Abdolalizadeh, Reza Rajimehr
Movement Disorders.2018; 33(3): 431.     CrossRef
Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
Mahsa Dolatshahi, Shayan Pourmirbabaei, Aida Kamalian, Amir Ashraf-Ganjouei, Mehdi Yaseri, Mohammad H. Aarabi
Frontiers in Neurology.2018;[Epub]     CrossRef
Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study
Manuel Delgado-Alvarado, Rosalía Dacosta-Aguayo, Irene Navalpotro-Gómez, Belén Gago, Ana Gorostidi, Haritz Jiménez-Urbieta, Ana Quiroga-Varela, Javier Ruiz-Martínez, Alberto Bergareche, María C. Rodríguez-Oroz
Movement Disorders.2018; 33(11): 1809.     CrossRef
Extracellular Vesicles as a Source of Urological Biomarkers: Lessons Learned From Advances and Challenges in Clinical Applications to Major Diseases
Ji-Young Choi, Sujin Kim, Hyo-Bum Kwak, Dong-Ho Park, Jae-Hyoung Park, Jeong-Seon Ryu, Chang-Shin Park, Ju-Hee Kang
International Neurourology Journal.2017; 21(2): 83.     CrossRef
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
Lori N. Eidson, George T. Kannarkat, Christopher J. Barnum, Jianjun Chang, Jaegwon Chung, Chelsea Caspell-Garcia, Peggy Taylor, Brit Mollenhauer, Michael G. Schlossmacher, Larry Ereshefsky, Mark Yen, Catherine Kopil, Mark Frasier, Kenneth Marek, Vicki S.
Journal of Neuroinflammation.2017;[Epub]     CrossRef
Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias
Julie A Fields
Archives of Clinical Neuropsychology.2017; 32(7): 786.     CrossRef